Insight Molecular Diagnostics EBITDA 2014-2025 | IMDX
Insight Molecular Diagnostics ebitda from 2014 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Insight Molecular Diagnostics Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-59 |
| 2023 | $-23 |
| 2022 | $6 |
| 2021 | $-49 |
| 2020 | $-29 |
| 2019 | $-22 |
| 2018 | $-14 |
| 2017 | $-18 |
| 2016 | $-11 |
| 2015 | $-8 |
| 2014 | $-5 |
| 2013 | $-3 |
| Insight Molecular Diagnostics Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-6 |
| 2024-12-31 | $-33 |
| 2024-09-30 | $-13 |
| 2024-06-30 | $-4 |
| 2024-03-31 | $-9 |
| 2023-12-31 | $-16 |
| 2023-09-30 | $-6 |
| 2023-06-30 | $-8 |
| 2023-03-31 | $6 |
| 2022-12-31 | $8 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $-14 |
| 2021-09-30 | $-12 |
| 2021-06-30 | $-12 |
| 2021-03-31 | $-11 |
| 2020-12-31 | $-7 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-8 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-5 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-4 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-3 |
| 2018-03-31 | $-4 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-7 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-4 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-3 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-1 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.075B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.259B | 57.58 |
| Doximity (DOCS) | United States | $11.613B | 51.53 |
| Hims & Hers Health (HIMS) | United States | $11.187B | 92.56 |
| Tempus AI (TEM) | United States | $10.529B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.158B | 0.00 |
| Hinge Health (HNGE) | United States | $4.347B | 0.00 |
| Privia Health (PRVA) | United States | $2.493B | 184.64 |
| Inspire Medical Systems (INSP) | United States | $2.355B | 34.62 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.607B | 8.49 |
| 10x Genomics (TXG) | United States | $1.516B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Schrodinger (SDGR) | United States | $1.367B | 0.00 |
| Azenta (AZTA) | United States | $1.283B | 55.96 |
| Clover Health Investments (CLOV) | United States | $1.257B | 0.00 |
| Evolent Health (EVH) | United States | $1.082B | 0.00 |
| Claritev (CTEV) | United States | $1.013B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.461B | 0.00 |
| Talkspace (TALK) | United States | $0.412B | 123.00 |
| Carlsmed (CARL) | $0.346B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.342B | 0.00 |
| TruBridge (TBRG) | United States | $0.288B | 50.50 |
| Nyxoah SA (NYXH) | Belgium | $0.239B | 0.00 |
| Outset Medical (OM) | United States | $0.221B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.188B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.92 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.088B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |